The Wan Lab is affiliated with the Department of Cancer Biology, Abramson Family Cancer Research Institute, Penn Epigenetics Institute, and Institute for Regenerative Medicine at the Perelman School of Medicine, University of Pennsylvania. We employ multidisciplinary approaches to investigate chromatin function and its dysregulation in cancer, with a particular emphasis on understanding how chromatin mechanisms regulate gene activity to impact cell fate control during tumorigenesis and metastasis. We are also actively engaged in translating basic mechanistic insights to the development of novel therapeutics.

Latest News

October 2024: Congratulations to Qinglan on being awarded a Postdoctoral Fellowship from our AFCRI cancer institute!

July 2024: Check out our new study on epigenetic mechanisms in kidney development and pathogenesis on bioRvix here!

June 2024: Check out our review article on transcriptional condensates here!

April 2024: Our study on condensate-promoting ENL mutations in AML is published at Cancer Discovery! Read more here

Interested in joining?

We are constantly looking for talented and passionate researchers (postdocs, graduate students, undergraduate and research technicians) to join our growing team! Please see Open Positions and contact Dr. Wan if interested.